Loading clinical trials...
Loading clinical trials...
the Effect of the Low Dose Nalbuphine Versus Dexmedetomidine on the Prevention of Emergence Agitation After Sevoflurane Anaesthesia in Children Undergoing ENT Surgeries
Conditions
Interventions
we will give the patient 0.1 mg nalbuphine 15 min before the end of the procedure
we will give the patient 0.5 mg dexmedetomidine 15 min before the end of the procedure
Locations
1
Egypt
Ainshams University
Cairo, Egypt, Egypt
Start Date
May 1, 2024
Primary Completion Date
November 1, 2024
Completion Date
November 1, 2024
Last Updated
February 17, 2025
NCT07427446
NCT07408037
NCT06326983
NCT07046364
NCT06761092
NCT07552259
Lead Sponsor
Ain Shams University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions